Navigation Links
Kiwa Bio-Tech Receives Nationally Recognized Organic Products Certification
Date:8/4/2008

BEIJING and CLAREMONT, Calif., Aug. 4 /Xinhua-PRNewswire-FirstCall/ -- Kiwa Bio-Tech Products Group Corporation (OTC Bulletin Board: KWBT) announces that Kiwa Bio-Tech Products (Shandong) Co., Ltd. (Kiwa Shandong) has received an Organic Products Certificate from the China Organic Food Certification Center (COFCC).

After a two-month period of examination, verification and appraisal of Kiwa Shandong's products, the China Organic Food Certification Center issued an Organic Products Certificate to Kiwa Shandong on July 18. COFCC is the specialized agency under the Chinese Ministry of Agriculture to propel the development of organic agriculture and to be engaged in authentication and management of organic food and the organic food industry. Moreover, it is the first national organic food qualification agency authorized and structured by the Certification and Accreditation Administration of the Peoples Republic of China (Grant No. CNCA-R-2002-100), and has acquired recognition by the China National Accreditation Service for Conformity Assessment (Registration No. CNAS C115-0).

Mr. Wei Li, Chairman and CEO of Kiwa, stated, "Kiwa Shandong is the second fertilizer manufacturing enterprise in Shandong Province of China, that has acquired Organic Products Certification. With this certification, orders for our organic fertilizer products should increase, and boost Kiwa Shandong's sales volume."

ABOUT KIWA BIO-TECH PRODUCTS GROUP CORPORATION

The Company develops, manufactures, distributes and markets innovative, cost-effective, and environmentally safe bio-technological products for agricultural and natural resources and environmental conservation. The Company's products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes. For more information about the Company, please review documents filed with the SEC (http://www.sec.gov) or visit the Company's website at http://www.kiwaiotech.com .

To see an English language video related to Kiwa's AF-01 anti-viral preventative for avian flu: http://video.google.com/videoplay?docid=-7160666649865130385 or http://www.youtube.com/watch?v=WF_9TTX_fSA ; http://www.youtube.com/watch?v=XG0gl9okjic

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward- looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

For more information, please contact:

Yvonne Wang

Kiwa Bio-Tech Products Group Corporation

Tel: +1-626-715-5855

Email: kiwabiotech@gmail.com

Robert Schechter

Equity Communications

Tel: +1-212-499-6809

Email: ir4kiwa@hotmail.com


'/>"/>
SOURCE Kiwa Bio-Tech Products Group Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million
2. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
3. Kiwa Bio-Tech Completes 1st Stage of Shandong Factory Upgrading
4. Advanced Bio-Technologies Inc Announces Acquisition by HealthEdge Investment Partners, Tampa FL
5. Kiwa Bio-Tech Ships 2,700 Tons of Bio-feed in One Month
6. Align Technology, Inc. Ranked 23rd in Deloittes Technology Fast 50 Program for Silicon Valley Scientific & Medical Equipment, and Bio-Technology Companies
7. Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million
8. Kiwa Bio-Tech Products Group Holds a Fertilizer Products Exhibition in Hebei
9. Kiwa Bio-Tech Products Group Holds Meetings to Build Distribution Network
10. Kiwa Bio-Tech Animal Feed Volume Increased 25% in Fourth Quarter of 2007
11. Kiwa Bio-Tech Ships 114 Tons of Bio-Fertilizer in Fourth Quarter of 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... -- Financial Highlights ... unaudited)Three Months Ended December 31,Twelve Months Ended December 31,20162015% ... $           300$   ... Product Revenue 3539(10)%9498(4)%Kuvan Net Product ... 756025%297303(2)%Vimizim Net Product Revenue ...
(Date:2/23/2017)... , Feb. 23, 2017  Seattle,s upscale Capitol Hill neighborhood, ... strange place for a head lice treatment salon to set ... a Tuscan restaurant and a French bistro on E Madison ... "We aren,t just any old lice clinic, we pride ourselves ... comfortable, and release some of the stigma associated with lice. ...
(Date:2/23/2017)... ... February 23, 2017 , ... Today, researchers can fast-track ... uric acid, and/or other biomarkers or SNPs of interest) using one, easy-to-collect saliva ... , the relationship between insulin and other relevant biomarkers can be extensively studied ...
(Date:2/23/2017)... ... February 22, 2017 , ... Seventy-one ... been named Fellows of the Society this year, the Fellows Committee has announced. ... fields of optics, photonics, and imaging as well as their service to the ...
Breaking Biology Technology:
(Date:2/16/2017)... Feb. 16, 2017  Genos, a community for ... it has received Laboratory Accreditation from the College ... presented to laboratories that meet stringent requirements around ... rigorous processes. "Genos is committed to ... practices. We,re honored to be receiving CAP accreditation," ...
(Date:2/10/2017)... Research and Markets has announced ... - Scientific and Commercial Aspects" to their offering. ... Biomarkers ... with therapy for selection of treatment as well for monitoring ... of disease in modern medicine. Biochip/microarray technologies and next generation ...
(Date:2/8/2017)... YORK , Feb. 7, 2017 Report Highlights ... The ... should reach $11.4 billion by 2021, growing at a compound ... Includes - An overview of the global markets for synthetic ... 2015, estimates for 2016, and projections of compound annual growth ...
Breaking Biology News(10 mins):